X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
comparative analysis (2) 2
adult (1) 1
adults (1) 1
aids (1) 1
anti-hiv agents - administration & dosage (1) 1
anti-hiv agents - pharmacokinetics (1) 1
anti-hiv agents - therapeutic use (1) 1
antiretroviral drugs (1) 1
antiretroviral therapy (1) 1
antiretroviral therapy, highly active (1) 1
antiretrovirals (1) 1
antiviral agents (1) 1
arts (1) 1
benzoxazines - administration & dosage (1) 1
benzoxazines - pharmacokinetics (1) 1
benzoxazines - therapeutic use (1) 1
cd4 lymphocyte count (1) 1
cells (1) 1
clinical trials (1) 1
dosage and administration (1) 1
drug interactions (1) 1
drug therapy (1) 1
efavirenz 600 mg/day (1) 1
female (1) 1
health aspects (1) 1
hiv 1 (1) 1
hiv infection (1) 1
hiv infections - complications (1) 1
hiv infections - drug therapy (1) 1
hiv-1 - isolation & purification (1) 1
hiv/aids (1) 1
human immunodeficiency virus--hiv (1) 1
humans (1) 1
immunology (1) 1
index medicus (1) 1
individuals (1) 1
infections (1) 1
infectious diseases (1) 1
male (1) 1
medical treatment failures (1) 1
microbiology (1) 1
middle aged (1) 1
mortality (1) 1
multivariate analysis (1) 1
nevirapine - administration & dosage (1) 1
nevirapine - pharmacokinetics (1) 1
nevirapine - therapeutic use (1) 1
nevirapine levels (1) 1
outcomes (1) 1
patient outcomes (1) 1
plasma - chemistry (1) 1
prospective studies (1) 1
reverse transcriptase inhibitors (1) 1
reverse transcriptase inhibitors - administration & dosage (1) 1
reverse transcriptase inhibitors - pharmacokinetics (1) 1
reverse transcriptase inhibitors - therapeutic use (1) 1
ribonucleic acid--rna (1) 1
rifampin (1) 1
rifampin - therapeutic use (1) 1
rna (1) 1
rna, viral - blood (1) 1
survival (1) 1
treatment outcome (1) 1
tuberculosis (1) 1
tuberculosis - drug therapy (1) 1
usage (1) 1
viral load (1) 1
virology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 6/2009, Volume 48, Issue 12, pp. 1752 - 1759
Background. To our knowledge, to date, no prospective, randomized, clinical trial has compared standard doses of efavirenz-and nevirapine-based antiretroviral... 
HIV/AIDS | Medical treatment failures | Antiretrovirals | Tuberculosis | Infectious diseases | RNA | AIDS | Infections | HIV 1 | Arts | Virology | INDIVIDUALS | SURVIVAL | MORTALITY | INFECTIOUS DISEASES | TUBERCULOSIS | ADULTS | MICROBIOLOGY | EFAVIRENZ 600 MG/DAY | ANTIRETROVIRAL THERAPY | OUTCOMES | IMMUNOLOGY | NEVIRAPINE LEVELS | Prospective Studies | Humans | Middle Aged | Male | Nevirapine - therapeutic use | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Viral Load | Anti-HIV Agents - administration & dosage | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Benzoxazines - pharmacokinetics | HIV-1 - isolation & purification | Tuberculosis - drug therapy | Adult | Anti-HIV Agents - therapeutic use | Female | Rifampin - therapeutic use | Reverse Transcriptase Inhibitors - therapeutic use | Benzoxazines - administration & dosage | Treatment Outcome | CD4 Lymphocyte Count | Benzoxazines - therapeutic use | Antiretroviral Therapy, Highly Active | Anti-HIV Agents - pharmacokinetics | Plasma - chemistry | HIV Infections - complications | HIV Infections - drug therapy | Nevirapine - administration & dosage | Nevirapine - pharmacokinetics | Antiviral agents | Usage | Patient outcomes | Reverse transcriptase inhibitors | Dosage and administration | Comparative analysis | Drug therapy | Rifampin | Health aspects | HIV infection | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.